Capacity of human β-defensin expression in gene-transduced and cytokine-induced cells

被引:4
|
作者
Yin, CY
Dang, HN
Zhang, HB
Gazor, F
Kim, D
Sorensen, OE
Huang, GTJ
机构
[1] Univ Calif Los Angeles, Sch Dent, Div Associated Clin Specialties, Sect Endodont, Los Angeles, CA 90024 USA
[2] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Los Angeles, CA 90024 USA
[3] Univ Calif Los Angeles, Sch Dent, Dent & Craniofacial Res Inst, Los Angeles, CA 90024 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Host Def Lab, Dept Med, Los Angeles, CA USA
关键词
HBD-2; HBD-3; lentiviral vectors; retroviral vectors; IL-1; TNF alpha; gingival epithelial cells;
D O I
10.1016/j.bbrc.2005.11.020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purpose of this study was to determine the capacity of cells transduced with human beta-defensins (HBDs) to express antimicrobial peptides, since sufficient expression level is required for effective antimicrobial activity. Retroviral vector pBabeNeo and lentiviral vector SIN18cPPTRhMLV (SIN 18) carrying HBDs were utilized to transduce non-H BD-expressing cells Such as fibroblasts or HBD-producing oral epithelial cells. We found that HBD-3 gene transfer to fibroblasts was possible not via retrovirus but by direct vector transfection. SIN18 had high transduction efficiencies (80.9-99.9%) and transduced cells expressed higher amounts of HBD-2 than those by pBabeNeo. Primary human gingival epithelial cells (HGECs) expressed greater amounts of HBD-2 than primary fibroblasts after lentiviral transduction. Additionally, HBD-2 secretion from transduced HGECs cells was further increased when stimulated with IL-1 or TNF alpha. our data indicate that while HBD-2 expression is limited in primary fibroblasts, its expression in HGECs may be maximized by gene transduction plus cytokine induction. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:344 / 354
页数:11
相关论文
共 50 条
  • [1] Mechanisms of vaccination with cytokine gene-transduced cells
    Forni, C
    Boggio, K
    Cavallo, F
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 598 - 598
  • [2] MINIMAL REQUIREMENTS FOR CHARACTERIZATION OF CYTOKINE GENE-TRANSDUCED TUMOR-CELLS - A PROPOSAL
    LOLLINI, PL
    NANNI, P
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (22) : 1717 - 1718
  • [3] Cytokine-induced IFN-gamma gene expression in human NK and T cells
    Sareneva, T
    Matikainen, S
    Miettinen, M
    Paananen, A
    Kurimoto, M
    Timonen, T
    Julkunen, I
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 543 - 543
  • [4] Modulation of immune responses induced by gene-transduced dendritic cells.
    Sonderbye, L
    Feng, S
    Bennekov, T
    Ahsan, N
    Yang, H
    Mulligan, R
    Langhoff, E
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 102 - 102
  • [5] Considerations for the clinical development of cytokine gene-transduced tumor cell vaccines
    Jaffee, EM
    Pardoll, DM
    METHODS, 1997, 12 (02) : 143 - 153
  • [6] Regulation of cytokine-induced Fas ligand expression in human mesangial cells
    Tsukinoki, T
    Sugiyama, H
    Sunami, R
    Maeshima, Y
    Yamasaki, Y
    Makino, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 294A - 294A
  • [7] Crosstalk between cytokine-induced apoptosis and cytokine-induced senescence in human cancer cells
    Burkhart, F.
    Rentschler, M.
    Weidemann, S.
    Braumueller, H.
    Bauer, B.
    Roecken, M.
    Wieder, T.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (03) : E86 - E87
  • [8] Development of a novel vaccination therapy against malignant gliomas utilizing cytokine gene-transduced tumor cells
    Hirakawa, K
    Wakimoto, H
    Aoyagi, M
    Hamada, H
    11TH INTERNATIONAL CONGRESS OF NEUROLOGICAL SURGERY, VOLS 1 AND 2, 1997, : 1717 - 1721
  • [9] Progesterone Receptor Signaling Selectively Modulates Cytokine-Induced Global Gene Expression in Human Cervical Stromal Cells
    Kniss, Douglas A.
    Summerfield, Taryn L.
    FRONTIERS IN GENETICS, 2020, 11
  • [10] Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets
    Ylipaasto, P
    Kutlu, B
    Rasilainen, S
    Rasschaert, J
    Salmela, K
    Teerijoki, H
    Korsgren, O
    Lahesmaa, R
    Hovi, T
    Eizirik, DL
    Otonkoski, T
    Roivainen, M
    DIABETOLOGIA, 2005, 48 (08) : 1510 - 1522